Overview
Biogen Inc., based in the United States, is a prominent biotechnology firm that operates primarily in the healthcare sector. The company is renowned for its pioneering work in neuroscience, focusing on developing therapies for neurodegenerative, hematologic, and autoimmune diseases. Key projects include research and development in areas like Alzheimer’s disease, multiple sclerosis, and spinal muscular atrophy. Biogen’s commitment to innovation is evident from its robust pipeline of potential treatments undergoing various stages of clinical trials. Additionally, Biogen is involved in collaborations that aim to advance the understanding of complex neurodegenerative diseases and improve the management of these conditions, further underscoring its role as a leader in biotechnological advancements within the neurological field.
AI+ Ask Fintel’s AI assistant about Biogen Inc..
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of Biogen Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 146.60 MM |
| Earnings Date | |
| EPS (TTM) | 10.44 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.06 |
| ROE | 0.10 |
| ROIC | 0.06 |
| CROIC | 0.03 |
| OCROIC | 0.08 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 33.14 /100 |
| Profitability | 64.64 /100 |
| Quality Score | 46.12 /100 |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | 18.66 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 5.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Biogen Inc. is CLP239.28. The forecasts range from a low of CLP184.83 to a high of CLP315.00. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
| Record Date | Projection Date | High | Low | Median | Average |
|---|---|---|---|---|---|
| 2023-12-19 | 2024-12-19 | 315.00 | 184.83 | 234.60 | 239.28 |
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Biogen Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-07-12 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-06-28 | Needham | Buy | Buy | Reiterate |
| 2024-06-27 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-06-26 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-06-05 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-05-29 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-05-23 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2024-05-22 | Needham | Buy | Buy | Reiterate |
| 2024-05-16 | Truist Securities | Buy | Buy | Maintains |
| 2024-05-03 | HSBC | Buy | Buy | Maintains |
| 2024-04-29 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-04-25 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-04-25 | Wedbush | Neutral | Neutral | Maintains |
| 2024-04-25 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2024-04-25 | Needham | Buy | Buy | Reiterate |
| 2024-04-24 | Needham | Buy | Buy | Reiterate |
| 2024-04-19 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-04-17 | UBS | Neutral | Neutral | Maintains |
| 2024-04-17 | Wedbush | Neutral | Neutral | Maintains |
| 2024-04-12 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-04-11 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-04-04 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-03-25 | Truist Securities | Buy | Buy | Reiterate |
| 2024-03-05 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-02-22 | Mizuho | Buy | Buy | Maintains |
| 2024-02-20 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-02-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-02-16 | UBS | Neutral | Neutral | Maintains |
| 2024-02-14 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-02-14 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-02-14 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-02-14 | Baird | Outperform | Outperform | Maintains |
| 2024-02-14 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-02-14 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2024-02-14 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2024-02-14 | Needham | Buy | Buy | Maintains |
| 2024-02-13 | Needham | Buy | Buy | Reiterate |
| 2024-01-30 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2024-01-25 | UBS | Buy | Neutral | Downgrade |
| 2024-01-24 | UBS | Buy | Neutral | Downgrade |
| 2023-12-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-12-18 | Oppenheimer | Outperform | Outperform | Maintains |
| 2023-12-14 | Stifel | Buy | Buy | Maintains |
| 2023-12-07 | Raymond James | Market Perform | Outperform | Upgrade |
| 2023-11-10 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-11-09 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-11-09 | Wedbush | Neutral | Neutral | Maintains |
| 2023-11-09 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-11-09 | BMO Capital | Outperform | Outperform | Maintains |
| 2023-10-26 | Wedbush | Neutral | Neutral | Maintains |
| 2023-10-26 | Needham | Buy | Buy | Reiterate |
| 2023-10-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-09-06 | HSBC | Buy | Initiate | |
| 2023-09-05 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-08-29 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-08-14 | Mizuho | Buy | Buy | Maintains |
| 2023-08-08 | Truist Securities | Buy | Buy | Maintains |
| 2023-08-08 | BMO Capital | Outperform | Outperform | Maintains |
| 2023-08-08 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2023-08-08 | Atlantic Equities | Neutral | Neutral | Maintains |
| 2023-08-08 | Needham | Buy | Buy | Maintains |
| 2023-08-07 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-08-07 | Oppenheimer | Outperform | Outperform | Maintains |
| 2023-08-07 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-07-31 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-07-31 | Needham | Buy | Buy | Reiterate |
| 2023-07-27 | Scotiabank | Sector Outperform | Initiate | |
| 2023-07-26 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-07-26 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-07-26 | Wedbush | Neutral | Neutral | Maintains |
| 2023-07-26 | BMO Capital | Outperform | Outperform | Maintains |
| 2023-07-26 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2023-07-26 | Needham | Buy | Buy | Maintains |
| 2023-07-25 | Stifel | Buy | Buy | Maintains |
| 2023-07-25 | Needham | Buy | Buy | Reiterate |
| 2023-07-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-07-11 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-07-07 | Needham | Buy | Buy | Reiterate |
| 2023-07-07 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2023-06-12 | Oppenheimer | Outperform | Outperform | Maintains |
| 2023-06-12 | Canaccord Genuity | Buy | Buy | Maintains |
| 2023-06-12 | Needham | Buy | Buy | Reiterate |
| 2023-06-12 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2023-06-08 | Barclays | Overweight | Maintains | |
| 2023-06-08 | Needham | Buy | Buy | Reiterate |
| 2023-06-07 | Baird | Outperform | Outperform | Reiterate |
| 2023-06-02 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-06-01 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-05-23 | Wedbush | Neutral | Neutral | Reiterate |
| 2023-05-11 | Argus Research | Buy | Buy | Maintains |
| 2023-05-04 | B of A Securities | Neutral | Maintains | |
| 2023-05-01 | Guggenheim | Neutral | Buy | Upgrade |
| 2023-04-26 | Canaccord Genuity | Buy | Maintains | |
| 2023-04-26 | RBC Capital | Outperform | Maintains | |
| 2023-04-26 | Wedbush | Neutral | Reiterate | |
| 2023-04-26 | Oppenheimer | Outperform | Maintains | |
| 2023-04-26 | HC Wainwright & Co. | Buy | Reiterate | |
| 2023-04-26 | Barclays | Equal-Weight | Maintains | |
| 2023-04-26 | Atlantic Equities | Neutral | Maintains | |
| 2023-04-26 | Morgan Stanley | Overweight | Maintains | |
| 2023-04-26 | Needham | Buy | Maintains | |
| 2023-04-21 | B of A Securities | Neutral | Maintains | |
| 2023-04-17 | Argus Research | Buy | Maintains | |
| 2023-04-17 | Wedbush | Neutral | Maintains | |
| 2023-04-17 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2023-04-12 | Morgan Stanley | Overweight | Maintains | |
| 2023-04-11 | Needham | Buy | Reiterate | |
| 2023-03-23 | HC Wainwright & Co. | Buy | Reiterate | |
| 2023-03-23 | Needham | Buy | Reiterate | |
| 2023-02-16 | RBC Capital | Outperform | Maintains | |
| 2023-02-16 | Morgan Stanley | Overweight | Maintains | |
| 2023-02-16 | UBS | Buy | Maintains | |
| 2023-02-16 | Cowen & Co. | Outperform | Maintains | |
| 2023-02-16 | Oppenheimer | Outperform | Maintains | |
| 2023-02-16 | HC Wainwright & Co. | Buy | Reiterate | |
| 2023-02-16 | Needham | Buy | Reiterate | |
| 2023-02-15 | Needham | Buy | Reiterate | |
| 2023-01-24 | Morgan Stanley | Overweight | Maintains | |
| 2022-12-01 | Atlantic Equities | Neutral | Maintains | |
| 2022-11-30 | Jefferies | Buy | Maintains | |
| 2022-11-30 | Wedbush | Neutral | Maintains | |
| 2022-11-30 | Barclays | Equal-Weight | Maintains | |
| 2022-11-15 | Truist Securities | Buy | Maintains | |
| 2022-11-14 | Oppenheimer | Outperform | Maintains | |
| 2022-11-11 | Guggenheim | Neutral | Maintains | |
| 2022-11-01 | Mizuho | Buy | Maintains | |
| 2022-10-26 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2022-10-26 | Morgan Stanley | Overweight | Maintains | |
| 2022-10-26 | RBC Capital | Outperform | Maintains | |
| 2022-10-26 | HC Wainwright & Co. | Buy | Maintains | |
| 2022-10-26 | SVB Leerink | Outperform | Maintains | |
| 2022-10-26 | Atlantic Equities | Neutral | Maintains | |
| 2022-10-24 | Jefferies | Buy | Maintains | |
| 2022-10-13 | Morgan Stanley | Overweight | Maintains | |
| 2022-10-13 | Stifel | Hold | Buy | Upgrade |
| 2022-10-07 | Argus Research | Hold | Buy | Upgrade |
| 2022-10-07 | Barclays | Equal-Weight | Maintains | |
| 2022-10-06 | UBS | Buy | Maintains | |
| 2022-09-30 | JP Morgan | Neutral | Maintains | |
| 2022-09-28 | Wedbush | Neutral | Maintains | |
| 2022-09-28 | Wells Fargo | Overweight | Maintains | |
| 2022-09-28 | RBC Capital | Outperform | Maintains | |
| 2022-09-28 | Piper Sandler | Neutral | Maintains | |
| 2022-09-28 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2022-09-28 | Baird | Neutral | Outperform | Upgrade |
| 2022-09-28 | Mizuho | Neutral | Buy | Upgrade |
| 2022-09-22 | Truist Securities | Buy | Maintains | |
| 2022-09-12 | Stifel | Hold | Maintains | |
| 2022-07-21 | Cowen & Co. | Outperform | Maintains | |
| 2022-07-21 | Barclays | Equal-Weight | Maintains | |
| 2022-07-21 | Truist Securities | Buy | Maintains | |
| 2022-07-21 | Needham | Buy | Maintains | |
| 2022-07-18 | Oppenheimer | Outperform | Maintains | |
| 2022-05-04 | Morgan Stanley | Overweight | Maintains | |
| 2022-05-04 | Oppenheimer | Outperform | Maintains | |
| 2022-05-04 | RBC Capital | Outperform | Maintains | |
| 2022-05-04 | Barclays | Equal-Weight | Maintains | |
| 2022-04-21 | SVB Leerink | Outperform | Maintains | |
| 2022-04-18 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2022-04-12 | Morgan Stanley | Overweight | Maintains | |
| 2022-04-12 | Barclays | Equal-Weight | Maintains | |
| 2022-04-08 | Needham | Buy | Maintains | |
| 2022-04-08 | Oppenheimer | Outperform | Maintains | |
| 2022-03-28 | B of A Securities | Neutral | Maintains | |
| 2022-03-08 | Stifel | Buy | Hold | Downgrade |
| 2022-03-03 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2022-02-07 | Canaccord Genuity | Buy | Maintains | |
| 2022-02-04 | Morgan Stanley | Overweight | Maintains | |
| 2022-02-04 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-02-04 | Needham | Buy | Maintains | |
| 2022-02-04 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2022-01-24 | SVB Leerink | Outperform | Maintains | |
| 2022-01-20 | Barclays | Equal-Weight | Maintains | |
| 2022-01-18 | Morgan Stanley | Overweight | Maintains | |
| 2022-01-18 | HC Wainwright & Co. | Buy | Maintains | |
| 2022-01-13 | Guggenheim | Buy | Neutral | Downgrade |
| 2022-01-12 | Mizuho | Neutral | Maintains | |
| 2022-01-12 | Wedbush | Neutral | Maintains | |
| 2022-01-12 | Needham | Buy | Maintains | |
| 2022-01-12 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2022-01-11 | Needham | Buy | Maintains | |
| 2022-01-06 | Morgan Stanley | Overweight | Maintains | |
| 2021-12-23 | B of A Securities | Neutral | Maintains | |
| 2021-12-22 | Oppenheimer | Outperform | Maintains | |
| 2021-12-21 | JP Morgan | Neutral | Maintains | |
| 2021-12-21 | Baird | Neutral | Maintains | |
| 2021-12-20 | SVB Leerink | Outperform | Maintains | |
| 2021-12-09 | Wells Fargo | Equal-Weight | Initiate | |
| 2021-12-06 | Goldman Sachs | Neutral | Initiate | |
| 2021-11-19 | RBC Capital | Sector Perform | Maintains | |
| 2021-11-19 | BMO Capital | Outperform | Initiate | |
| 2021-10-26 | Mizuho | Neutral | Maintains | |
| 2021-10-21 | Cowen & Co. | Outperform | Maintains | |
| 2021-10-21 | Morgan Stanley | Overweight | Maintains | |
| 2021-10-21 | RBC Capital | Sector Perform | Maintains | |
| 2021-10-21 | Oppenheimer | Outperform | Maintains | |
| 2021-10-21 | Needham | Buy | Maintains | |
| 2021-10-19 | Needham | Buy | Maintains | |
| 2021-10-15 | Cantor Fitzgerald | Neutral | Maintains | |
| 2021-10-15 | Stifel | Buy | Maintains | |
| 2021-10-12 | Morgan Stanley | Overweight | Maintains | |
| 2021-10-08 | Jefferies | Buy | Maintains | |
| 2021-10-08 | Barclays | Equal-Weight | Maintains | |
| 2021-09-29 | RBC Capital | Sector Perform | Maintains | |
| 2021-09-23 | Needham | Buy | Initiate | |
| 2021-09-16 | UBS | Buy | Maintains | |
| 2021-08-02 | Mizuho | Neutral | Maintains | |
| 2021-07-27 | Canaccord Genuity | Buy | Maintains | |
| 2021-07-23 | Morgan Stanley | Overweight | Maintains | |
| 2021-07-23 | RBC Capital | Sector Perform | Maintains | |
| 2021-07-16 | Morgan Stanley | Overweight | Maintains | |
| 2021-06-28 | RBC Capital | Sector Perform | Maintains | |
| 2021-06-18 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2021-06-14 | Goldman Sachs | Neutral | Maintains | |
| 2021-06-14 | Truist Securities | Buy | Maintains | |
| 2021-06-11 | Bernstein | Market Perform | Outperform | Upgrade |
| 2021-06-10 | UBS | Neutral | Buy | Upgrade |
| 2021-06-10 | SVB Leerink | Outperform | Maintains | |
| 2021-06-08 | William Blair | Market Perform | Outperform | Upgrade |
| 2021-06-08 | Barclays | Equal-Weight | Maintains | |
| 2021-06-08 | Jefferies | Buy | Maintains | |
| 2021-06-08 | RBC Capital | Sector Perform | Maintains | |
| 2021-06-08 | Citigroup | Sell | Neutral | Upgrade |
| 2021-06-08 | Morgan Stanley | Overweight | Maintains | |
| 2021-06-08 | Baird | Underperform | Neutral | Upgrade |
| 2021-06-08 | HC Wainwright & Co. | Buy | Maintains | |
| 2021-05-18 | Oppenheimer | Outperform | Maintains | |
| 2021-04-19 | Morgan Stanley | Overweight | Maintains | |
| 2021-04-12 | Wedbush | Neutral | Maintains | |
| 2021-02-17 | Cantor Fitzgerald | Neutral | Maintains | |
| 2021-02-04 | Credit Suisse | Outperform | Maintains | |
| 2021-02-04 | Morgan Stanley | Overweight | Maintains | |
| 2021-02-04 | HC Wainwright & Co. | Buy | Maintains | |
| 2021-02-04 | SVB Leerink | Outperform | Maintains | |
| 2021-01-19 | Morgan Stanley | Overweight | Maintains | |
| 2020-11-19 | RBC Capital | Sector Perform | Maintains | |
| 2020-11-10 | DZ Bank | Hold | Buy | Upgrade |
| 2020-11-09 | Cowen & Co. | Outperform | Market Perform | Downgrade |
| 2020-11-09 | B of A Securities | Neutral | Underperform | Downgrade |
| 2020-11-09 | HC Wainwright & Co. | Buy | Maintains | |
| 2020-11-09 | Atlantic Equities | Neutral | Underweight | Downgrade |
| 2020-11-09 | SVB Leerink | Outperform | Maintains | |
| 2020-11-05 | BMO Capital | Market Perform | Maintains | |
| 2020-11-05 | B of A Securities | Underperform | Neutral | Upgrade |
| 2020-11-05 | SVB Leerink | Outperform | Maintains | |
| 2020-10-28 | UBS | Neutral | Initiate | |
| 2020-10-27 | Mizuho | Neutral | Maintains | |
| 2020-10-22 | Credit Suisse | Outperform | Maintains | |
| 2020-10-22 | Wedbush | Neutral | Maintains | |
| 2020-10-22 | Morgan Stanley | Overweight | Maintains | |
| 2020-10-20 | Piper Sandler | Neutral | Maintains | |
| 2020-10-15 | B of A Securities | Underperform | Maintains | |
| 2020-10-13 | Morgan Stanley | Overweight | Maintains | |
| 2020-09-18 | RBC Capital | Sector Perform | Maintains | |
| 2020-08-19 | SVB Leerink | Outperform | Maintains | |
| 2020-07-27 | Morgan Stanley | Underweight | Overweight | Upgrade |
| 2020-07-15 | Morgan Stanley | Underweight | Maintains | |
| 2020-06-22 | RBC Capital | Sector Perform | Maintains | |
| 2020-06-22 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2020-06-19 | Baird | Underperform | Maintains | |
| 2020-06-09 | Bernstein | Outperform | Market Perform | Downgrade |
| 2020-05-01 | Cantor Fitzgerald | Neutral | Reiterate | |
| 2020-04-24 | Canaccord Genuity | Buy | Maintains | |
| 2020-04-23 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-04-23 | Oppenheimer | Outperform | Maintains | |
| 2020-04-23 | Credit Suisse | Neutral | Maintains | |
| 2020-04-23 | Morgan Stanley | Underweight | Maintains | |
| 2020-04-23 | Raymond James | Market Perform | Underperform | Downgrade |
| 2020-04-23 | Citigroup | Neutral | Sell | Downgrade |
| 2020-04-23 | Barclays | Overweight | Maintains | |
| 2020-02-27 | Barclays | Overweight | Initiate | |
| 2020-02-25 | Mizuho | Neutral | Maintains | |
| 2020-02-07 | Nomura | Buy | Maintains | |
| 2020-02-06 | SVB Leerink | Outperform | Maintains | |
| 2020-02-06 | Credit Suisse | Neutral | Maintains | |
| 2020-02-06 | Cantor Fitzgerald | Neutral | Reiterate | |
| 2020-02-06 | Morgan Stanley | Underweight | Maintains | |
| 2020-02-06 | Baird | Underperform | Maintains | |
| 2020-02-06 | Wells Fargo | Equal-Weight | Maintains | |
| 2020-02-03 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-01-31 | Morgan Stanley | Underweight | Maintains | |
| 2020-01-27 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2020-01-17 | Morgan Stanley | Underweight | Maintains | |
| 2019-12-13 | Credit Suisse | Underperform | Neutral | Upgrade |
| 2019-12-02 | Baird | Neutral | Underperform | Downgrade |
| 2019-11-12 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2019-11-01 | Standpoint Research | Buy | Hold | Downgrade |
| 2019-10-30 | Bernstein | Market Perform | Outperform | Upgrade |
| 2019-10-23 | Canaccord Genuity | Hold | Maintains | |
| 2019-10-23 | H.C. Wainwright | Buy | Reiterate | |
| 2019-10-23 | JP Morgan | Neutral | Maintains | |
| 2019-10-23 | Cowen & Co. | Outperform | Maintains | |
| 2019-10-23 | Credit Suisse | Underperform | Maintains | |
| 2019-10-23 | Guggenheim | Neutral | Buy | Upgrade |
| 2019-10-23 | BMO Capital | Market Perform | Maintains | |
| 2019-10-23 | Morgan Stanley | Underweight | Maintains | |
| 2019-10-23 | SVB Leerink | Market Perform | Outperform | Upgrade |
| 2019-10-11 | Morgan Stanley | Underweight | Maintains | |
| 2019-07-24 | Canaccord Genuity | Hold | Maintains | |
| 2019-06-28 | Piper Jaffray | Overweight | Neutral | Downgrade |
| 2019-05-23 | Wedbush | Neutral | Initiate | |
| 2019-05-21 | Credit Suisse | Underperform | Initiate | |
| 2019-05-09 | Barclays | Equal-Weight | Maintains | |
| 2019-03-22 | Morgan Stanley | Overweight | Underweight | Downgrade |
| 2019-03-22 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2019-03-22 | Citigroup | Buy | Neutral | Downgrade |
| 2019-03-22 | Nomura | Buy | Buy | Maintains |
| 2019-03-22 | UBS | Buy | Neutral | Downgrade |
| 2019-03-22 | Mizuho | Buy | Neutral | Downgrade |
| 2019-03-21 | William Blair | Outperform | Market Perform | Downgrade |
| 2019-03-21 | Cantor Fitzgerald | Overweight | Neutral | Downgrade |
| 2019-03-21 | Atlantic Equities | Overweight | Neutral | Downgrade |
| 2019-02-22 | BMO Capital | Market Perform | Initiate | |
| 2019-02-22 | Guggenheim | Buy | Neutral | Downgrade |
| 2019-02-21 | Stifel Nicolaus | Buy | Hold | Downgrade |
| 2018-12-21 | BTIG Research | Buy | Initiate | |
| 2018-12-19 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-10-24 | JP Morgan | Overweight | Overweight | Maintains |
| 2018-10-19 | Bernstein | Outperform | Market Perform | Downgrade |
| 2018-07-26 | UBS | Buy | Buy | Maintains |
| 2018-07-25 | Baird | Neutral | Neutral | Maintains |
| 2018-07-25 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2018-07-25 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-07-23 | Canaccord Genuity | Buy | Buy | Maintains |
| 2018-07-13 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-07-10 | Baird | Outperform | Neutral | Downgrade |
| 2018-07-06 | Citigroup | Neutral | Buy | Upgrade |
| 2018-05-31 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2018-05-02 | Citigroup | Neutral | Neutral | Maintains |
| 2018-04-25 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-25 | Baird | Neutral | Outperform | Upgrade |
| 2018-04-05 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2018-03-05 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-02-16 | Argus | Buy | Hold | Downgrade |
| 2018-02-05 | Mizuho | Buy | Buy | Maintains |
| 2018-01-31 | UBS | Neutral | Buy | Upgrade |
| 2018-01-26 | H.C. Wainwright | Buy | Buy | Maintains |
| 2018-01-26 | Oppenheimer | Outperform | Outperform | Maintains |
| 2018-01-24 | Canaccord Genuity | Hold | Hold | Maintains |
| 2017-11-09 | Oppenheimer | Outperform | Initiate | |
| 2017-11-06 | BMO Capital | Outperform | Maintains | |
| 2017-10-27 | Canaccord Genuity | Hold | Initiate | |
| 2017-10-25 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2017-10-25 | UBS | Neutral | Maintains | |
| 2017-10-24 | Guggenheim | Buy | Initiate | |
| 2017-10-23 | Citigroup | Buy | Neutral | Downgrade |
| 2017-10-18 | Bank of America | Buy | Maintains | |
| 2017-10-17 | Stifel Nicolaus | Hold | Buy | Upgrade |
| 2017-10-17 | Mizuho | Neutral | Buy | Upgrade |
| 2017-10-05 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2017-09-21 | Raymond James | Strong Buy | Market Perform | Downgrade |
| 2017-09-20 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2017-09-15 | RBC Capital | Sector Perform | Initiate | |
| 2017-09-13 | BMO Capital | Market Perform | Maintains | |
| 2017-08-16 | Goldman Sachs | Buy | Conviction Buy | Upgrade |
| 2017-07-26 | BMO Capital | Market Perform | Maintains | |
| 2017-07-26 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2017-07-26 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-07-26 | UBS | Neutral | Maintains | |
| 2017-07-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-06-23 | Deutsche Bank | Buy | Initiate | |
| 2017-06-19 | UBS | Sell | Neutral | Upgrade |
| 2017-03-16 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2017-03-16 | Leerink Swann | Outperform | Market Perform | Downgrade |
| 2017-02-08 | Citigroup | Neutral | Buy | Upgrade |
| 2017-02-07 | Citigroup | Neutral | Buy | Upgrade |
| 2016-12-16 | Cantor Fitzgerald | Neutral | Initiate | |
| 2016-11-08 | Mizuho | Neutral | Initiate | |
| 2016-11-07 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2016-11-07 | Leerink Swann | Market Perform | Outperform | Upgrade |
| 2016-10-05 | Jefferies | Hold | Maintains | |
| 2016-09-06 | Jefferies | Buy | Hold | Downgrade |
| 2016-08-17 | Morgan Stanley | Overweight | Maintains | |
| 2016-08-02 | Standpoint Research | Buy | Hold | Downgrade |
| 2016-08-02 | Raymond James | Strong Buy | Maintains | |
| 2016-07-21 | Morgan Stanley | Overweight | Maintains | |
| 2016-06-29 | Bernstein | Outperform | Initiate | |
| 2016-06-08 | Citigroup | Buy | Maintains | |
| 2016-06-07 | Citigroup | Buy | Neutral | Downgrade |
| 2016-04-21 | Goldman Sachs | Neutral | Maintains | |
| 2016-04-05 | BMO Capital | Market Perform | Initiate | |
| 2016-03-11 | Baird | Neutral | Maintains | |
| 2016-02-25 | Citigroup | Buy | Initiate | |
| 2016-02-05 | Leerink Swann | Market Perform | Initiate | |
| 2016-01-28 | Jefferies | Buy | Maintains | |
| 2016-01-20 | Credit Suisse | Neutral | Initiate | |
| 2016-01-07 | Standpoint Research | Buy | Initiate | |
| 2015-12-18 | Atlantic Equities | Overweight | Initiate | |
| 2015-11-05 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2015-10-15 | Jefferies | Buy | Maintains | |
| 2015-09-15 | Leerink Swann | Outperform | Maintains | |
| 2015-09-09 | Jefferies | Buy | Initiate | |
| 2015-08-11 | H.C. Wainwright | Buy | Initiate | |
| 2015-07-27 | Morgan Stanley | Overweight | Maintains | |
| 2015-07-27 | Bernstein | Market Perform | Outperform | Upgrade |
| 2015-07-27 | Baird | Outperform | Neutral | Downgrade |
| 2015-07-22 | PiperJaffray | Overweight | Neutral | Downgrade |
| 2015-07-14 | Bank of America | Neutral | Buy | Upgrade |
| 2015-06-11 | Leerink Swann | Outperform | Maintains | |
| 2015-06-10 | Leerink Swann | Outperform | Maintains | |
| 2015-04-27 | Citigroup | Buy | Maintains | |
| 2015-04-27 | Nomura | Neutral | Maintains | |
| 2015-03-30 | BMO Capital | Outperform | Maintains | |
| 2015-03-23 | Stifel Nicolaus | Buy | Hold | Downgrade |
| 2015-03-23 | Citigroup | Buy | Maintains | |
| 2015-02-03 | Leerink Swann | Outperform | Maintains | |
| 2015-01-30 | Stifel Nicolaus | Buy | Maintains | |
| 2015-01-30 | Barclays | Overweight | Maintains | |
| 2015-01-30 | Citigroup | Buy | Maintains | |
| 2015-01-06 | Barclays | Overweight | Initiate | |
| 2015-01-05 | Nomura | Buy | Neutral | Downgrade |
| 2014-11-19 | Credit Suisse | Outperform | Maintains | |
| 2014-10-23 | Citigroup | Buy | Maintains | |
| 2014-10-22 | Baird | Neutral | Outperform | Upgrade |
| 2014-07-24 | UBS | Neutral | Maintains | |
| 2014-07-24 | Jefferies | Buy | Maintains | |
| 2014-07-24 | Credit Suisse | Outperform | Maintains | |
| 2014-07-24 | Nomura | Buy | Maintains | |
| 2014-07-24 | Deutsche Bank | Buy | Maintains | |
| 2014-05-29 | JP Morgan | Neutral | Overweight | Upgrade |
| 2014-04-28 | Jefferies | Buy | Maintains | |
| 2014-04-24 | Nomura | Buy | Maintains | |
| 2014-03-27 | Morgan Stanley | Overweight | Initiate | |
| 2014-03-19 | Stifel Nicolaus | Buy | Maintains | |
| 2014-03-07 | Barclays | Overweight | Maintains | |
| 2014-03-06 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2014-02-14 | Credit Suisse | Outperform | Maintains | |
| 2014-01-28 | Deutsche Bank | Buy | Maintains | |
| 2014-01-16 | Stifel Nicolaus | Buy | Maintains | |
| 2014-01-08 | Nomura | Buy | Initiate | |
| 2013-11-25 | Citigroup | Buy | Maintains | |
| 2013-11-22 | Citigroup | Buy | Maintains | |
| 2013-11-22 | Deutsche Bank | Buy | Maintains | |
| 2013-11-22 | Credit Suisse | Outperform | Maintains | |
| 2013-10-02 | FBR Capital | Outperform | Maintains | |
| 2013-07-26 | BMO Capital | Market Perform | Maintains | |
| 2013-07-01 | Citigroup | Neutral | Buy | Upgrade |
| 2013-06-12 | Citigroup | Buy | Neutral | Downgrade |
| 2013-04-22 | Deutsche Bank | Buy | Maintains | |
| 2013-04-19 | Citigroup | Buy | Maintains | |
| 2013-04-12 | UBS | Neutral | Maintains | |
| 2013-04-12 | Bank of America | Neutral | Buy | Upgrade |
| 2013-04-09 | RBC Capital | Outperform | Maintains | |
| 2013-04-04 | Credit Suisse | Outperform | Maintains | |
| 2013-03-28 | Goldman Sachs | Buy | Maintains | |
| 2013-03-28 | JMP Securities | Market Outperform | Initiate | |
| 2013-03-28 | Jefferies | Buy | Maintains | |
| 2013-03-28 | Bank of America | Neutral | Maintains | |
| 2013-03-28 | Canaccord Genuity | Buy | Maintains | |
| 2013-03-28 | Stifel Nicolaus | Buy | Maintains | |
| 2013-03-25 | Morgan Stanley | Overweight | Maintains | |
| 2013-03-22 | Bank of America | Neutral | Maintains | |
| 2013-03-04 | Credit Suisse | Outperform | Maintains | |
| 2013-02-27 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2013-02-08 | Citigroup | Neutral | Buy | Upgrade |
| 2013-02-08 | Credit Suisse | Outperform | Maintains | |
| 2013-02-07 | Jefferies | Buy | Maintains | |
| 2013-02-06 | Deutsche Bank | Buy | Maintains | |
| 2013-01-29 | Jefferies | Buy | Maintains | |
| 2013-01-29 | UBS | Neutral | Maintains | |
| 2013-01-03 | Bank of America | Buy | Maintains | |
| 2013-01-03 | PiperJaffray | Overweight | Neutral | Downgrade |
| 2013-01-03 | Canaccord Genuity | Hold | Maintains | |
| 2013-01-03 | Oppenheimer | Perform | Maintains | |
| 2012-12-17 | Canaccord Genuity | Hold | Initiate | |
| 2012-11-21 | Brean Capital | Buy | Initiate | |
| 2012-10-26 | BMO Capital | Market Perform | Maintains | |
| 2012-10-18 | PiperJaffray | Overweight | Maintains | |
| 2012-10-15 | Barclays | Overweight | Maintains | |
| 2012-10-08 | Credit Suisse | Outperform | Maintains | |
| 2012-10-04 | Oppenheimer | Outperform | Perform | Downgrade |
| 2012-09-27 | Jefferies | Buy | Maintains | |
| 2012-09-27 | Stifel Nicolaus | Buy | Maintains | |
| 2012-09-26 | Bank of America | Buy | Maintains | |
| 2012-09-10 | UBS | Buy | Neutral | Downgrade |
| 2012-09-06 | Deutsche Bank | Buy | Maintains | |
| 2012-07-25 | Morgan Stanley | Overweight | Maintains | |
| 2012-07-25 | UBS | Buy | Maintains | |
| 2012-07-25 | Jefferies | Buy | Maintains | |
| 2012-07-24 | Citigroup | Neutral | Maintains | |
| 2012-07-09 | Stifel Nicolaus | Buy | Maintains | |
| 2012-05-09 | UBS | Buy | Maintains | |
| 2012-05-02 | Jefferies | Buy | Maintains | |
| 2012-05-01 | PiperJaffray | Overweight | Maintains | |
| 2012-05-01 | Citigroup | Neutral | Maintains | |
| 2012-05-01 | Oppenheimer | Outperform | Maintains | |
| 2012-04-25 | Oppenheimer | Outperform | Maintains | |
| 2012-02-10 | Morgan Stanley | Overweight | Initiate | |
| 2024-07-26 | Needham | Buy | Buy | Reiterate |
| 2024-11-04 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-12-20 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2024-08-06 | Mizuho | Outperform | Outperform | Maintains |
| 2024-08-05 | Truist Securities | Buy | Buy | Reiterate |
| 2024-08-05 | Needham | Buy | Buy | Maintains |
| 2024-10-31 | TD Cowen | Buy | Buy | Maintains |
| 2024-10-31 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-31 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-10-31 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2024-10-31 | Needham | Buy | Buy | Reiterate |
| 2024-10-31 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2024-08-02 | Scotiabank | Sector Outperform | Sector Outperform | Maintains |
| 2024-08-02 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-08-02 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-09-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-05-02 | Canaccord Genuity | Buy | Buy | Maintains |
| 2025-05-02 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-05-02 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2025-05-02 | Needham | Hold | Hold | Reiterate |
| 2025-05-02 | Baird | Outperform | Outperform | Maintains |
| 2024-11-21 | Mizuho | Outperform | Outperform | Maintains |
| 2025-01-08 | Truist Securities | Buy | Buy | Maintains |
| 2025-01-10 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-09-19 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-08-01 | Needham | Buy | Buy | Reiterate |
| 2024-10-17 | BMO Capital | Outperform | Outperform | Maintains |
| 2025-08-14 | Piper Sandler | Neutral | Neutral | Maintains |
| 2024-11-15 | Baird | Outperform | Outperform | Maintains |
| 2024-11-15 | Wolfe Research | Peer Perform | Initiate | |
| 2024-11-14 | Citigroup | Neutral | Initiate | |
| 2024-08-02 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-08-02 | Wedbush | Neutral | Neutral | Maintains |
| 2024-08-19 | Needham | Buy | Buy | Reiterate |
| 2025-02-13 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-13 | Citigroup | Neutral | Neutral | Maintains |
| 2025-02-13 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-02-13 | Goldman Sachs | Buy | Buy | Maintains |
| 2025-02-13 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-13 | BMO Capital | Market Perform | Market Perform | Maintains |
| 2025-02-13 | Scotiabank | Sector Outperform | Sector Outperform | Maintains |
| 2025-02-13 | Truist Securities | Buy | Buy | Maintains |
| 2025-02-13 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2024-10-30 | Needham | Buy | Buy | Reiterate |
| 2025-01-28 | Citigroup | Neutral | Neutral | Maintains |
| 2024-09-04 | Needham | Buy | Buy | Reiterate |
| 2024-10-03 | UBS | Neutral | Neutral | Maintains |
| 2024-07-29 | Baird | Outperform | Outperform | Maintains |
| 2024-11-18 | Needham | Buy | Hold | Downgrade |
| 2024-10-04 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-06-12 | Wedbush | Neutral | Neutral | Reiterate |
| 2025-06-12 | Needham | Hold | Hold | Reiterate |
| 2024-12-10 | B of A Securities | Neutral | Reiterate | |
| 2024-12-09 | Jefferies | Buy | Hold | Downgrade |
| 2025-02-13 | Canaccord Genuity | Buy | Buy | Maintains |
| 2025-02-13 | Needham | Hold | Hold | Reiterate |
| 2024-09-24 | Needham | Buy | Buy | Reiterate |
| 2024-09-23 | Wedbush | Neutral | Neutral | Maintains |
| 2024-10-10 | Raymond James | Market Perform | Reiterate | |
| 2025-05-07 | Mizuho | Outperform | Outperform | Maintains |
| 2025-01-02 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2025-04-16 | Needham | Hold | Hold | Reiterate |
| 2025-02-18 | Piper Sandler | Neutral | Neutral | Reiterate |
| 2025-04-09 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-04-04 | Argus Research | Buy | Hold | Downgrade |
| 2025-04-25 | Needham | Hold | Hold | Reiterate |
| 2025-04-29 | Truist Securities | Buy | Buy | Maintains |
| 2025-06-25 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-06-12 | Piper Sandler | Neutral | Neutral | Reiterate |
| 2025-08-01 | Citigroup | Neutral | Neutral | Maintains |
| 2025-08-01 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-08-01 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-01 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2025-04-29 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-05-05 | JP Morgan | Neutral | Neutral | Maintains |
| 2025-06-27 | RBC Capital | Outperform | Outperform | Reiterate |
| 2025-09-04 | Needham | Hold | Hold | Reiterate |
| 2025-04-23 | Goldman Sachs | Buy | Buy | Maintains |
| 2025-04-22 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-06-26 | HC Wainwright & Co. | Buy | Buy | Reiterate |
